Boothbay Fund Management, LLC Relmada Therapeutics, Inc. Call Options Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$18.3 - $37.02 $1.8 Million - $3.64 Million	98,200 Added 256.4%	136,500 $5.05 Million
Q2 2022 Aug 15, 2022	BUY	$16.5 - $30.34 $631,950 - $1.16 Million	38,300 New	38,300 $727,000
Q3 2021 Nov 15, 2021	SELL	$21.86 - $34.77 $513,710 - $817,095	-23,500 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$29.55 - $39.15 $694,425 - $920,025	23,500 New	23,500 $752,000

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $11.7M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.